Rise and shine, everyone. Another busy day has arrived. And this is shaping up to be a pleasant one, too. A warm sun is enveloping the Pharmalot campus, where the official mascots are snoozing and we are exercising our new coffee kettle. As usual, there is much to do and we assume you can relate. So time to get cracking. Here are a few items of interest for you to peruse. Have a productive day and keep us in mind when something interesting happens…
Valeant Pharmaceuticals sought to reassure doctors that cutting ties with Philidor Rx Services, a mail-order pharmacy, would not disrupt their ability to prescribe its drugs; The South African government is considering a recommendation by Doctors Without Borders to allow generic versions of the Lopinavir HIV drug after shortages resulted in interruptions to some treatments; and AbbVie has vowed to keep biosimilars of its Humira rheumatoid arthritis treatment from reaching the US market before 2022.